Phio Pharmaceuticals PHIO Stock
Phio Pharmaceuticals Price Chart
Phio Pharmaceuticals PHIO Financial and Trading Overview
| Phio Pharmaceuticals stock price | 2.04 USD |
| Previous Close | 3.15 USD |
| Open | 3.11 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 1100 |
| Day's Range | 3.09 - 3.27 USD |
| 52 Week Range | 2.89 - 12.27 USD |
| Volume | 26.42K USD |
| Avg. Volume | 583.91K USD |
| Market Cap | 5.92M USD |
| Beta (5Y Monthly) | 1.514788 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -9.08 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 72 USD |
PHIO Valuation Measures
| Enterprise Value | -4157620 USD |
| Trailing P/E | N/A |
| Forward P/E | 0.16615853 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.51463646 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.336 |
Trading Information
Phio Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.514788 |
| 52-Week Change | -59.26% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 12.27 USD |
| 52 Week Low | 2.89 USD |
| 50-Day Moving Average | 4.01 USD |
| 200-Day Moving Average | 5.6 USD |
PHIO Share Statistics
| Avg. Volume (3 month) | 583.91K USD |
| Avg. Daily Volume (10-Days) | 57.04K USD |
| Shares Outstanding | 1.81M |
| Float | 1.14M |
| Short Ratio | 0.08 |
| % Held by Insiders | 1.18% |
| % Held by Institutions | 3.18% |
| Shares Short | 103.29K |
| Short % of Float | 6.91% |
| Short % of Shares Outstanding | 6.85% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -48.73% |
| Return on Equity (ttm) | -92.96% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -154000 USD |
| EBITDA | -12359000 USD |
| Net Income Avi to Common (ttm) | -12440000 USD |
| Diluted EPS (ttm) | -11.49 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.04M USD |
| Total Cash Per Share (mrq) | 6.01 USD |
| Total Debt (mrq) | 138K USD |
| Total Debt/Equity (mrq) | 1.89 USD |
| Current Ratio (mrq) | 3.925 |
| Book Value Per Share (mrq) | 6.354 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -11368000 USD |
| Levered Free Cash Flow (ttm) | -6604000 USD |
Profile of Phio Pharmaceuticals
| Country | United States |
| State | MA |
| City | Marlborough |
| Address | 257 Simarano Drive |
| ZIP | 01752 |
| Phone | 508 767 3861 |
| Website | https://www.phiopharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 9 |
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. The company develops PH-762, INTASYL compound which reduces the expression of cell death Protein 1 (PD-1), a protein that inhibits T cells' ability to kill cancer cells; PH-894 that silences the BRD4, a protein which controls gene expression in both T cells and tumor cells, effecting the immune system as well as the tumor; and PH-804 that targets the TIGIT, a protein which inhibits the activity of Natural Killer cells. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.
Q&A For Phio Pharmaceuticals Stock
What is a current PHIO stock price?
Phio Pharmaceuticals PHIO stock price today per share is 2.04 USD.
How to purchase Phio Pharmaceuticals stock?
You can buy PHIO shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Phio Pharmaceuticals?
The stock symbol or ticker of Phio Pharmaceuticals is PHIO.
Which industry does the Phio Pharmaceuticals company belong to?
The Phio Pharmaceuticals industry is Biotechnology.
How many shares does Phio Pharmaceuticals have in circulation?
The max supply of Phio Pharmaceuticals shares is 5.22M.
What is Phio Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Phio Pharmaceuticals PE Ratio is now.
What was Phio Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Phio Pharmaceuticals EPS is -9.08 USD over the trailing 12 months.
Which sector does the Phio Pharmaceuticals company belong to?
The Phio Pharmaceuticals sector is Healthcare.
Phio Pharmaceuticals PHIO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17382.94 USD — |
+1.26
|
6.5B USD — | 17110.72 USD — | 17404.49 USD — | — - | 6.5B USD — |
| NASDAQ Capital Market Composite RCMP | 102.15 USD — |
-0.54
|
— — | 101.35 USD — | 102.39 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 923.51 USD — |
-0.73
|
— — | 917.75 USD — | 925.61 USD — | — - | — — |
- {{ link.label }} {{link}}